Cargando…
Involvement of AMP-activated protein kinase and Death Receptor 5 in TRAIL-Berberine-induced apoptosis of cancer cells
Our previous studies indicated that combination of Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and PPARγ ligand Troglitazone (TZD), can induce significant apoptosis in various TRAIL-resistant prostate and hepatocellular carcinoma (HCC) cells. These also suggested serine/threonine...
Autores principales: | Ke, Rong, Vishnoi, Kanchan, Viswakarma, Navin, Santha, Sreevidya, Das, Subhasis, Rana, Ajay, Rana, Basabi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882856/ https://www.ncbi.nlm.nih.gov/pubmed/29615720 http://dx.doi.org/10.1038/s41598-018-23780-x |
Ejemplares similares
-
Modulation of glycogen synthase kinase-3β following TRAIL combinatorial treatment in cancer cells
por: Santha, Sreevidya, et al.
Publicado: (2016) -
Transcription Factors in Cancer Development and Therapy
por: Vishnoi, Kanchan, et al.
Publicado: (2020) -
Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma
por: Vishnoi, Kanchan, et al.
Publicado: (2022) -
Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis
por: Viswakarma, Navin, et al.
Publicado: (2017) -
Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer
por: Kumar, Sandeep, et al.
Publicado: (2020)